BR8406921A - Compositions dry-compression, direct to the controlled release dosage forms - Google Patents

Compositions dry-compression, direct to the controlled release dosage forms

Info

Publication number
BR8406921A
BR8406921A BR8406921A BR8406921A BR8406921A BR 8406921 A BR8406921 A BR 8406921A BR 8406921 A BR8406921 A BR 8406921A BR 8406921 A BR8406921 A BR 8406921A BR 8406921 A BR8406921 A BR 8406921A
Authority
BR
Brazil
Prior art keywords
compression
direct
dosage forms
controlled release
release dosage
Prior art date
Application number
BR8406921A
Other languages
Portuguese (pt)
Inventor
Choong-Gook Jang
Original Assignee
Choong Gook Jang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US49922183A priority Critical
Priority to US60047284A priority
Application filed by Choong Gook Jang filed Critical Choong Gook Jang
Priority to PCT/US1984/000807 priority patent/WO1984004674A1/en
Publication of BR8406921A publication Critical patent/BR8406921A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
BR8406921A 1983-05-31 1984-05-29 Compositions dry-compression, direct to the controlled release dosage forms BR8406921A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US49922183A true 1983-05-31 1983-05-31
US60047284A true 1984-04-16 1984-04-16
PCT/US1984/000807 WO1984004674A1 (en) 1983-05-31 1984-05-29 Dry direct compression compositions for controlled release dosage forms

Publications (1)

Publication Number Publication Date
BR8406921A true BR8406921A (en) 1985-06-04

Family

ID=27053077

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8406921A BR8406921A (en) 1983-05-31 1984-05-29 Compositions dry-compression, direct to the controlled release dosage forms

Country Status (5)

Country Link
EP (1) EP0147437A4 (en)
JP (1) JPH0759502B2 (en)
AU (2) AU581177B2 (en)
BR (1) BR8406921A (en)
WO (1) WO1984004674A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524003A1 (en) 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Drug granules sustained release and process for its manufacture
SE455836B (en) * 1985-10-11 1988-08-15 Haessle Ab Preparation controlled frisettning CONTAINING a salt of metoprolol and method for forward tell up of this preparation
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
US4983399A (en) * 1989-10-18 1991-01-08 Eastman Kodak Company Direct compression carrier composition
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US5458888A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
CA2447444A1 (en) 2001-05-11 2002-11-21 Orasense, Ltd. Antisense permeation enhancers
US20030012820A1 (en) * 2001-06-12 2003-01-16 Upadhyay Ajay Hasmukhlal Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom
RU2437662C2 (en) 2006-04-07 2011-12-27 Меррион Рисерч Iii Лимитед Solid per oral medication, containing intensifier
BRPI0912384A2 (en) 2008-05-07 2015-10-13 Merrion Res Iii Ltd composition and method for preparing a composition
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
BR112013017169A2 (en) 2011-01-07 2016-10-04 Merrion Res Iii Ltd iron pharmaceutical compositions for oral administration
US20130259937A1 (en) * 2011-12-02 2013-10-03 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions
CN107205948A (en) 2015-01-29 2017-09-26 诺和诺德股份有限公司 Tablets comprising glp-1 agonist and enteric coating

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564759A (en) * 1955-12-22
US3402240A (en) * 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same
US3279998A (en) * 1962-06-22 1966-10-18 Smith Kline French Lab Method of preparing sustained release tablets
BE636865A (en) * 1962-08-31
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
US3336200A (en) * 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
NL297631A (en) * 1963-06-03
US3362880A (en) * 1963-09-20 1968-01-09 Dow Chemical Co Compressed drug tablets of ethyl cellulose, glyceryl monostearate, karaya gum, tragacanth, talc, and magnesium stearate
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
DE2050701C3 (en) * 1969-10-17 1979-12-20 Shinetsu Chemical Co., Tokio
FR2183546B1 (en) * 1972-05-10 1975-06-20 Servier Lab
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
ZA8306627B (en) * 1982-10-08 1984-05-30 Verex Lab Constant release rate solid oral dosage formulation of pharmaceutical compounds having a high degree of water solubility
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system

Also Published As

Publication number Publication date
EP0147437A4 (en) 1987-03-05
WO1984004674A1 (en) 1984-12-06
JPS60501459A (en) 1985-09-05
JPH0759502B2 (en) 1995-06-28
AU3475189A (en) 1989-09-07
AU581177B2 (en) 1989-02-16
EP0147437A1 (en) 1985-07-10
AU2967684A (en) 1984-12-18

Similar Documents

Publication Publication Date Title
DE3382401D1 (en) Photoresist composition.
FI830203L (en) Syrahydrolys, alkaliextraktion, materialbehandling
FI850514L (en) Mineralpulver, Vilket at Formning ger, rapidly I Høg styrka.
SE411547B (en) Certain specified carboxyalkyl-2-cyanoacrylate priority over that to the binder, particularly as vevnadsbindemedel in surgical applications
BR8307289A (en) Polymeric compositions TERMOPLASTICAS
NO803674L (en) Water absorbent composition.
FI834522A (en) 1-azolyl-2-aryl-3-fluoralkan-2-Oler som mikrobicider.
FI845038L (en) Vattenloeslig, aminerad Bound -1,3-d-glucanase Science composition innehaollande densamma.
FI854241A0 (en) The compositions Orala.
FI831368L (en) The compositions with the effect can foerdroejd
FI822487A0 (en) The compositions ytaktiva Skummande
FI822296A0 (en) The compositions Tvaettmedelsfoereningar- Science
FI850254A0 (en) Hydrofobisk composition, and the mixture foerfarande.
IT1206501B (en) Compositions analgesic, anti-inflammatory and improved caffeinated.
FI821013A0 (en) The compositions
DK114783A (en) Novel compounds, to processes for their preparation and their use as medicaments
FI865037A0 (en) The compositions Mikrobicida.
FI844204L (en) The compositions.
FI822191A0 (en) The mixture farmaceutisk
FI851128L (en) The compositions Mellandestillat with baettre kallrinningsegenskaper.
NO842338L (en) New gem-diaminoalkanderivater useful as soetningsmidler.
NO834731L (en) The composition
BR8005033A (en) Cleaning composition
NO831762L (en) Farmasoeytiske compositions.
ES2017922B3 (en) 3-amino-4,5-dihydroxypiperidines, process for their preparation, and their use.